DE69435301D1 - Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung - Google Patents

Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung

Info

Publication number
DE69435301D1
DE69435301D1 DE69435301T DE69435301T DE69435301D1 DE 69435301 D1 DE69435301 D1 DE 69435301D1 DE 69435301 T DE69435301 T DE 69435301T DE 69435301 T DE69435301 T DE 69435301T DE 69435301 D1 DE69435301 D1 DE 69435301D1
Authority
DE
Germany
Prior art keywords
angiotensin
analogues
tissue repair
wound healing
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69435301T
Other languages
English (en)
Inventor
Kathleen Elizabeth Rodgers
Gere Stodder Dizerega
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Application granted granted Critical
Publication of DE69435301D1 publication Critical patent/DE69435301D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69435301T 1993-09-24 1994-09-19 Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung Expired - Lifetime DE69435301D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12637093A 1993-09-24 1993-09-24

Publications (1)

Publication Number Publication Date
DE69435301D1 true DE69435301D1 (de) 2010-08-26

Family

ID=22424466

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69435301T Expired - Lifetime DE69435301D1 (de) 1993-09-24 1994-09-19 Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung

Country Status (9)

Country Link
US (1) US5716935A (de)
EP (2) EP0745091A4 (de)
JP (1) JPH09503205A (de)
AT (1) ATE473995T1 (de)
AU (1) AU697504B2 (de)
CA (1) CA2172494A1 (de)
DE (1) DE69435301D1 (de)
WO (1) WO1995008565A1 (de)
ZA (1) ZA947337B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902790A (en) * 1995-10-03 1999-05-11 Cytran, Inc. Pharmaceutical angiostatic dipeptide compositions and method of use thereof
US5955430A (en) * 1993-09-24 1999-09-21 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
AU758319B2 (en) * 1994-11-14 2003-03-20 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
US5834432A (en) * 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US6110895A (en) * 1996-12-16 2000-08-29 University Of Southern California Method of promoting healing in skin grafts
US6335195B1 (en) * 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
WO1998033813A2 (en) * 1997-02-04 1998-08-06 University Of Southern California Method for accelerating healing of thermal injuries
US6248587B1 (en) 1997-11-26 2001-06-19 University Of Southern Cailfornia Method for promoting mesenchymal stem and lineage-specific cell proliferation
US6165978A (en) * 1997-12-12 2000-12-26 University Of Southern California Wound healing composition
EP1053004A2 (de) 1998-02-09 2000-11-22 University Of Southern California Verwendung von angiotensin-analoga zur forderung der erythropoiesis
US6455500B1 (en) 1998-03-10 2002-09-24 University Of Southern California Radiation therapy methods
WO1999045945A1 (en) * 1998-03-10 1999-09-16 University Of Southern California Improved radiation therapy methods
US7173011B2 (en) 2000-11-20 2007-02-06 University Of Southern California Radiation therapy methods
WO1999046285A2 (en) 1998-03-11 1999-09-16 University Of Southern California Method of promoting production of living tissue equivalents
ATE292976T1 (de) 1998-05-11 2005-04-15 Univ Southern California Verwendung von angiotensin analogen zur herstellung eines arzneimittels zur steigerung des ueberlebens der weissen blutzellen und mobilisierung von haematopoietischen stammzellen nach einer chemotherapeutischen behandlung
US6762167B1 (en) 1998-05-11 2004-07-13 University Of Southern California Methods for treating a patient undergoing chemotherapy
JP3686335B2 (ja) 1998-07-13 2005-08-24 ユニヴァースティ オブ サザーン カリフォルニア 骨および軟骨成長と修復を促進する方法
US6916783B2 (en) 1998-07-13 2005-07-12 University Of Southern California Methods for accelerating bone and cartilage growth and repair
EP1105149A1 (de) 1998-08-13 2001-06-13 University Of Southern California Verfahren zur erhöhung der blutströmung zu ischämischen geweben
EP1158997A2 (de) * 1999-03-09 2001-12-05 University Of Southern California Verfahren zür förderung der proliferation von mukellzellen und der herzbewebsheilung
EP1165099B1 (de) * 1999-03-23 2006-08-09 University Of Southern California Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US7338938B2 (en) 1999-05-10 2008-03-04 University Of Southern California Methods for treating a patient undergoing chemotherapy
US6821953B1 (en) * 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
CA2430010A1 (en) 2000-11-30 2002-06-06 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
AU2002308522A1 (en) * 2001-05-01 2002-11-11 University Of Southern California Methods for inhibiting tumor cell proliferation
US20090227507A1 (en) * 2008-03-10 2009-09-10 University Of Southern California Angiotensin (1-7) Dosage Forms and Uses Thereof
BR112013019513A2 (pt) 2011-02-02 2019-06-11 Univ Southern California métodos para o tratamento de úlceras diabéticas do pé
US8557958B1 (en) 2012-06-18 2013-10-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of diabetes
US8633158B1 (en) 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
CN105873598A (zh) 2013-07-03 2016-08-17 代表亚利桑那大学的亚利桑那校董会 用于治疗认知功能障碍的方法
US9333233B2 (en) 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke
US10183055B2 (en) 2014-07-21 2019-01-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
WO2016014342A2 (en) 2014-07-21 2016-01-28 Arizona Board Of Regents For The University Of Arizona Ang-(1-7) derviative oligopeptides and methods for using and producing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015629A (en) * 1989-06-26 1991-05-14 University Of Southern California Tissue repair

Also Published As

Publication number Publication date
CA2172494A1 (en) 1995-03-30
ATE473995T1 (de) 2010-07-15
WO1995008565A1 (en) 1995-03-30
JPH09503205A (ja) 1997-03-31
AU7836494A (en) 1995-04-10
ZA947337B (en) 1995-05-10
US5716935A (en) 1998-02-10
EP1333034B1 (de) 2010-07-14
EP0745091A1 (de) 1996-12-04
EP1333034A1 (de) 2003-08-06
EP0745091A4 (de) 1998-05-20
AU697504B2 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
DE69435301D1 (de) Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung
DK0730465T3 (da) Anvendelse af angiotensin III og analoger dertil til vævsreparation
MX9703609A (es) Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
ATE378075T1 (de) Biologisch resorbierbare kalzium phosphate zement-zusammensetzungen
ATE187646T1 (de) Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung
DE69824445D1 (de) Zusammensetzungen zur wundheilung
ES2088006T3 (es) Composiciones farmaceuticas osteoinductivas.
DK0717634T3 (da) Injicerbare sammensætninger til forstørrelse af blødt væv
ATE193037T1 (de) Hochkonzentrierte homogenisierte kollagenzusammensetzungen
DE59305359D1 (de) Desodorierende kosmetische zubereitungen mit einem gehalt an di- oder triglycerinestern
MX9304787A (es) Prodrogas de acidos de imidazolcarboxilicos y composiciones farmaceuticasque las contienen.
FR2816838B1 (fr) Utilisation de derives de l'acide 2-oxothiazolidine- 4-carboxylique comme agents prodesquamants
DE69721556D1 (de) Mundwasser mit kalzium- und phosphationen in einer übersättigten lösung
ES2094171T3 (es) Composicion que contiene proteasa producida mediante vibrio, y procedimiento utilizado en el desbridamiento y curacion de heridas.
BR9707247A (pt) Diidrobenzofurano e compostos relacionados úteis como agentes antiinflamatórios
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
ES2067783T3 (es) Material para lentes de contacto y lentes de contacto preparadas a partir de dicho material.
DE59407098D1 (de) Verwendung von diglycerinestern gegen unreine haut
DE69033606D1 (de) Verfahren zur verbesserung der wundheilung und gewebeerneuerung
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
BR0109139B1 (pt) composiÇÕes farmacÊuticas incluindo alginatos
ATE63684T1 (de) Deodorant.
MX9709983A (es) El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos.
DK0520372T3 (da) Inositol-phosphat-analoger som calciumantagonistiske stoffer
CO5070608A1 (es) Metodo para aumentar la permeabilidad del tejido corneo humano